UW Telepain on Medical Marijuana
Tell a Friend About This EventTell a Friend
 

8/10/2016
When: Wednesday, August 10
12:00-1:30 PM
Presenter: Greg Carter, MD

« Go to Upcoming Event List  

Wednesday Session:                                       

Greg Carter, MD                                       

“Medical Marijuana”


To Join via Telephone:

The telephone call-in number is 646-568-7788  ID 359 845 443 

As always, please mute your telephone when you connect  *6.

 

To Join via Zoom (and previous adobe participants):

Open a web browser on a computer,  Iphone, Android.

Zoom.us/j/359845443 (answer all question to run/launch/Ok software install)

 

Technical contact for Wednesday sessions is Rande Gray at rgray@uw.edu or cell 206-459-7946 or office at 206-616-7257


 

The University of Washington School of Medicine designates this live activity for a maximum of 72 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.5 credits)

 

OBJECTIVES: Upon completion of this activity, attendees should be able to:

  1. Describe the different major types of chronic, non-cancer pain and their corresponding treatment modalities.
  2. Optimize pharmacologic treatment of chronic non-cancer pain to improve function and safety, as measured by ability to measure morphine equivalent doses in patient prescriptions.
  3. Detect unsafe combination therapies such as opioids and benzodiazepines.
  4. Identify non-pharmacologic treatment modalities available for patients.
  5. State the legal requirements applicable to treatment of pain and addicted patients in their setting.
  6. Be able to describe the screening tools useful for management of chronic pain in primary care setting including those measuring pain intensity, function, and addiction risk.
  7. Identify elements of safe opioid prescribing and be able to assess patients for treatment.
  8. Model effective communication skills to improve provider-patient interaction and build trust as well as demonstrate ways to manage requests for opioid therapy from patients for whom this type of therapy is appropriate, and those for whom it is not appropriate.
  9. Describe the risks of serious adverse outcomes from opioid use, according to characteristics of opioid regimens and patients, and apply this knowledge in their patient assessment and ongoing treatment plans for improved patient safety.
  10. Successfully document treatment and patient action plans, and know how to counsel patients on how to safely use, store and dispose of opioid medications.
  11. Discuss general and product-specific drug information concerning extended-release and long-acting opioids.

UW TelePain Team Contacts

 

Sam Galey

Program Assistant, UW Anesthesiology and Pain Medicine

University of Washington School of Medicine

smg1190@uw.edu

Contact about joining TelePain sessions, about obtaining CME, and about faxing in cases to present

 

David Tauben, MD

Associate Clinical Professor, UW Pain – tauben@uw.edu

Contact for clinical questions


Membership Software Powered by YourMembership  ::  Legal